Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Sanofi ADR (SNY) stocks
Learn how to easily invest in Sanofi ADR stocks.
Sanofi ADR is a drug manufacturers-general business based in the US. Sanofi ADR stocks (SNY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $52.59 – a decrease of 4.43% over the previous week. Sanofi ADR employs 91,573 staff and has a trailing 12-month revenue of around $46.2 billion.
How to buy Sanofi ADR stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SNY. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Sanofi ADR?
- Has coronavirus impacted Sanofi ADR shares?
- Sanofi ADR shares summary
- Compare share dealing platforms
- Is Sanofi ADR stock a buy or sell?
- Sanofi ADR performance over time
- Are Sanofi ADR shares over-valued?
- Sanofi ADR's financials
- How volatile are Sanofi ADR shares?
- Does Sanofi ADR pay a dividend?
- Have Sanofi ADR shares ever split?
- Other common questions
Sanofi ADR stock price (NASDAQ:SNY)Use our graph to track the performance of SNY stocks over time.
Sanofi ADR shares at a glance
|Latest market close||$52.59|
|52-week range||$36.91 - $57.82|
|50-day moving average||$53.96|
|200-day moving average||$46.84|
|Wall St. target price||$63.75|
|Dividend yield||$0 (3.53%)|
|Earnings per share (TTM)||$3.59|
Buy Sanofi ADR stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Sanofi ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sanofi ADR price performance over time
Historical closes compared with the close of $52.59 from 2023-05-25
|1 week (2023-05-19)||-4.43%|
|1 month (2023-04-27)||-6.24%|
|3 months (2023-02-27)||9.91%|
|6 months (2022-11-25)||15.86%|
|1 year (2022-05-27)||-4.64%|
|2 years (2021-05-27)||-0.70%|
|3 years (2020-05-27)||10.74%|
|5 years (2018-05-25)||37.38%|
Is Sanofi ADR stock undervalued or overvalued?
Valuing Sanofi ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sanofi ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sanofi ADR's P/E ratio
Sanofi ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Sanofi ADR shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Sanofi ADR's PEG ratio
Sanofi ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6501. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sanofi ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Sanofi ADR's EBITDA
Sanofi ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.4 billion.
The EBITDA is a measure of a Sanofi ADR's overall financial performance and is widely used to measure a its profitability.
Sanofi ADR financials
|Revenue TTM||$46.2 billion|
|Operating margin TTM||24.43%|
|Gross profit TTM||$31.7 billion|
|Return on assets TTM||5.59%|
|Return on equity TTM||11.77%|
|Market capitalisation||$132.7 billion|
TTM: trailing 12 months
Sanofi ADR share dividends
Dividend payout ratio: 50.12% of net profits
Recently Sanofi ADR has paid out, on average, around 50.12% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.53% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sanofi ADR shareholders could enjoy a 3.53% return on their shares, in the form of dividend payments. In Sanofi ADR's case, that would currently equate to about $0 per share.
Sanofi ADR's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Sanofi ADR's most recent dividend payout was on 23 June 2023. The latest dividend was paid out to all shareholders who bought their shares by 25 May 2023 (the "ex-dividend date").
Have Sanofi ADR's shares ever split?
Sanofi ADR's shares were split on a 5:1 basis on 30 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Sanofi ADR shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Sanofi ADR shares which in turn could have impacted Sanofi ADR's share price.
Sanofi ADR share price volatility
Over the last 12 months, Sanofi ADR's shares have ranged in value from as little as $36.91 up to $57.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sanofi ADR's is 0.4035. This would suggest that Sanofi ADR's shares are less volatile than average (for this exchange).
Sanofi ADR overview
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc.
Stocks similar to Sanofi ADR
Sanofi ADR in the news
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
2 Bear Market Defying Stocks to Buy in May
Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
Camera financing in Canada
Compare six ways to finance a camera in Canada, including options for good and bad credit.
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
Personal loans in Saskatchewan up to $50,000
Compare lenders to find the best personal loan in Saskatchewan for your needs.
Compare bad credit loans in Winnipeg
Compare interest rates and eligibility requirements of bad credit loans in Winnipeg.
Money Management for Teens: 7 Tips from Financial Experts
Teaching teenagers how to budget can be a tricky task. 7 experts give their best tips on how to budget for teenagers.